For this purpose, expression levels of CK20, DEFA5, PLS3, and LAD1 in blood samples of IBD patients were correlated with disease duration (Figure 4A) and the intake of immunosuppressive drugs (Figure 4D). This evidence concerns the gene PLS3 and inflammatory bowel disease.